Cargando…
Bevacizumab-induced immunoglobulin A vasculitis with nephritis: A case report
RATIONALE: Bevacizumab—an inhibitor of vascular endothelial growth factor—is effective against various advanced cancers. However, it is associated with the development of hypertension and high-grade proteinuria during thrombotic microangiopathy of the kidney. In addition, there are several reports o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855607/ https://www.ncbi.nlm.nih.gov/pubmed/31702653 http://dx.doi.org/10.1097/MD.0000000000017870 |